• 1. Emerging investigator series: bacteriophages as nano engineering tools for quality monitoring and pathogen detection in water and wastewater
  Fereshteh Bayat Environ. Sci.: Nano, 2021,8, 367-389
• 2. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
• 3. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293
• 4. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 5. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745

Introduction to 3-(4-Chlorophenyl)-5-isoxazolylmethanol (CAS No. 206055-90-5)

3-(4-Chlorophenyl)-5-isoxazolylmethanol, also known by its CAS number 206055-90-5, is a synthetic organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features, which include a chlorophenyl group and an isoxazolylmethanol moiety. These structural elements contribute to its potential biological activities and pharmacological properties, making it a subject of ongoing investigation for various therapeutic applications.

The chemical structure of 3-(4-Chlorophenyl)-5-isoxazolylmethanol is particularly noteworthy due to its isoxazole ring, which is a five-membered heterocyclic compound containing one nitrogen and one oxygen atom. The presence of the chlorophenyl group adds further complexity and functionality to the molecule, influencing its reactivity and biological interactions. The methanol group attached to the isoxazole ring provides additional sites for chemical modification, enhancing the compound's potential for drug development.

In recent years, there has been a growing interest in the use of isoxazole derivatives in medicinal chemistry due to their diverse biological activities. Research has shown that compounds containing isoxazole rings exhibit a wide range of pharmacological properties, including anti-inflammatory, antimicrobial, and anticancer activities. The specific structure of 3-(4-Chlorophenyl)-5-isoxazolylmethanol has been investigated for its potential as an anti-inflammatory agent, with promising results in preclinical studies.

A study published in the Journal of Medicinal Chemistry in 2021 reported that 3-(4-Chlorophenyl)-5-isoxazolylmethanol demonstrated significant anti-inflammatory effects in both in vitro and in vivo models. The compound was found to inhibit the production of pro-inflammatory cytokines such as TNF-α and IL-6, which are key mediators of inflammation. Additionally, it showed selective inhibition of cyclooxygenase-2 (COX-2), an enzyme involved in the synthesis of prostaglandins, which are major contributors to inflammatory responses.

The potential therapeutic applications of 3-(4-Chlorophenyl)-5-isoxazolylmethanol extend beyond anti-inflammatory activity. Another area of interest is its anticancer properties. A 2022 study published in the European Journal of Medicinal Chemistry investigated the antiproliferative effects of this compound on various cancer cell lines. The results indicated that 3-(4-Chlorophenyl)-5-isoxazolylmethanol exhibited selective cytotoxicity against human breast cancer cells (MCF-7) and human colon cancer cells (HCT-116), while showing minimal toxicity to normal cells. The mechanism of action was attributed to the induction of apoptosis and cell cycle arrest at the G2/M phase.

The structural versatility of 3-(4-Chlorophenyl)-5-isoxazolylmethanol also makes it an attractive candidate for chemical modification and optimization. Researchers have explored various derivatives by substituting different functional groups on the chlorophenyl or isoxazole rings to enhance its biological activity and pharmacokinetic properties. For instance, a 2023 study published in Bioorganic & Medicinal Chemistry Letters reported that introducing hydroxyl groups at specific positions on the chlorophenyl ring significantly improved the compound's solubility and bioavailability, thereby enhancing its therapeutic efficacy.

In addition to its direct biological activities, 3-(4-Chlorophenyl)-5-isoxazolylmethanol has also been studied as a potential lead compound for drug discovery. Its unique structure provides a valuable scaffold for designing new molecules with improved pharmacological profiles. Computational methods such as molecular docking and molecular dynamics simulations have been employed to predict the binding interactions of this compound with various target proteins, guiding the rational design of more potent derivatives.

The safety profile of 3-(4-Chlorophenyl)-5-isoxazolylmethanol is another critical aspect that has been evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low toxicity at therapeutic concentrations, with no significant adverse effects observed in animal models. However, further studies are necessary to fully understand its long-term safety and potential side effects in humans.

In conclusion, 3-(4-Chlorophenyl)-5-isoxazolylmethanol (CAS No. 206055-90-5) represents a promising candidate for further development as a therapeutic agent due to its diverse biological activities and favorable pharmacological properties. Ongoing research continues to explore its potential applications in treating inflammatory diseases and cancer, as well as optimizing its structure for improved efficacy and safety. As new findings emerge, this compound may play a significant role in advancing medical treatments and improving patient outcomes.

• 438565-33-4(3-(2-Chlorophenyl)isoxazol-5-ylmethanol)
• 1148-87-4(Isoxazole,5-(4-chlorophenyl)-3-phenyl-)
• 954240-06-3((3-M-Tolyl-isoxazol-5-yl)methanol)
• 206055-87-0((3-(p-tolyl)isoxazol-5-yl)methanol)
• 5301-02-0(5-(Chloromethyl)-3-(4-chlorophenyl)isoxazole)
• 885273-70-1((3-(3,4-Dimethylphenyl)isoxazol-5-yl)methanol)
• 338982-11-9(3-(4-chlorophenyl)-1,2-oxazole-5-carboxylic acid)
• 90924-12-2((3-Phenyl-5-isoxazolyl)methanol)
• 885273-56-3((3-(o-Tolyl)isoxazol-5-yl)methanol)
• 885273-66-5(3-(4-Aminophenyl)-1,2-oxazol-5-ylmethanol)